Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Patrick Clarence Machado

Affiliations

  • Director at Adverum Biotechnologies Inc. (ADVM), 2019-08-02
  • Other at Arbutus Biopharma Corp (ABUS), 2019-07-16
  • Other at Myovant Sciences Ltd. (MYOV), 2019-07-16
  • Other at Axovant Gene Therapies Ltd. (AXON), 2019-07-16
  • Other at Urovant Sciences Ltd. (UROV), 2019-07-16
  • Director at Chimerix Inc (CMRX), 2019-06-24
  • Director at Principia Biopharma Inc. (PRNB), 2019-06-11
  • Director at Turning Point Therapeutics Inc. (TPTX), 2019-05-14
  • Director at Scynexis Inc (SCYX), 2019-01-04
  • Director at Endocyte Inc (ECYT), 2018-12-21
  • Director at Inotek Pharmaceuticals Corp (ITEK), 2017-06-21
  • Director at Medivation Inc. (MDVN), 2016-09-30
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
UROV $8.17 4,957 Large Shareholder 22,860,013 2019-06-19 Filing
UROV $8.21 6,706 Large Shareholder 22,855,056 2019-06-18 Filing
UROV $8.53 6,541 Large Shareholder 22,848,350 2019-06-17 Filing
UROV $7.91 7,144 Large Shareholder 22,841,809 2019-06-14 Filing
UROV $7.95 7,367 Large Shareholder 22,834,665 2019-06-13 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MDVN $39.19 6,950 Director 66,156 2016-01-19 Filing
MDVN $38.62 7,942 Director 73,106 2016-01-19 Filing
MDVN $37.50 23,087 Director 81,048 2016-01-19 Filing
MDVN $36.62 37,021 Director 104,135 2016-01-19 Filing
MDVN $43.92 17,680 Director 66,156 2015-09-25 Filing